期刊文献+

肝硬化自发性腹膜炎患者腹水内毒素和C-反应蛋白水平的检测及临床意义 被引量:5

Detection and clinical significance of endotoxin and CRP in ascites of liver cirrhosis patients with spontaneous bacterial peritonitis
原文传递
导出
摘要 目的:探讨肝硬化腹水合并自发性腹膜炎患者腹水内毒素、C-反应蛋白(CRP)水平的变化及其临床意义。方法:根据腹水的性质,将58例肝炎后肝硬化腹水患者分为两组,自发性腹膜炎组(SBP)组30例,无菌性腹水组(SA)28例。应用鲎试剂动态比浊法及免疫散射比浊法测定两组患者腹水中内毒素和CRP水平并进行比较。25例SBP组患者用抗生素治疗有效后重新抽取腹水进行内毒素和CRP测定,并与治疗前结果进行比较。结果:SBP组腹水内毒素、CRP水平显著高于SA组(P<0.01),SBP组治疗前后腹水内毒素、CRP水平有差异统计学意义(P<0.01)。结论:检测腹水中内毒素和CRP的水平有助于SBP的早期诊断和疗效监测。 Objective: To study the changes and clinical significance of the levels of endotoxin and CRP in ascites in liver cirrhosis eases with spontaneous bacterial peritonitis (SBP). Methods: According to the features of aseites, fifty - eight patients with ascites of liver cirrhosis were divided into SBP group (30 eases) and sterile asciticfluid(SA) group (28 eases). The levels of endotoxin and CRP were measured respectively by the turbidimetric assay with limtdus reagents and RIA and con.pared between SBP group and SA group. Of 30 cases of SBP, the results of endotoxin and CRP were also compared before and after therapy with antibiotic in 25 cases of SBP. Results: There were significant differences in the levels of endotoxin and CRP in aseites between SBP group and SA group ( P 〈 0. 01 ). The levels of endotoxin and CRP after treatment were significantly lower than those before treatment in SBP group (P 〈 0.01 ). Conclusion: Measurement of endotoxin and CRP in ascites is helpful for physicians to diagnose SBP and observe its curative effect.
出处 《中国卫生检验杂志》 北大核心 2013年第6期1530-1531,共2页 Chinese Journal of Health Laboratory Technology
基金 杭州市医药卫生科技计划项目(2010B0129)
关键词 自发性腹膜炎 腹水 内毒素 C-反应蛋白 Spontaneous bacterial peritonitis Ascites Endotoxin C - reactive protein
  • 相关文献

参考文献6

二级参考文献59

共引文献2014

同被引文献38

  • 1中华医学会传染病与寄生虫病学分会;中华医学会肝病学分会.病毒性肝炎防治方案[J]中华传染病杂志,2001(01).
  • 2pourakbari B,Mamishi S,Zafari J, et al. Evaluation of / pro-calcitonin and neopterin level in serum of patients with acute baceterial infection [J]. Braz J Infect Dis, 2010,14:252-255.
  • 3Semenova TS,Pal'tseva EM,Zhigalova SB,et al.Portal hypertensive gastropathy[J].Arkh Patol,2014,76(6):64-68.
  • 4Qureshi K,Al-Osaimi AM.Approach to the management of portal hypertensive gastropathy and gastric antral vascular ectasia[J].Gastroenterol Clin North Am,2014,43(4):835-847.
  • 5Paltseva EM,Semenova TS,Zhigalova SB,et al.Expression of plasminogen activator system components in the gastric mucosa in portal hypertensive gastropathy[J].Arkh Patol,2015,77(2):16-21.
  • 6Zardi EM,Ghittoni G,Margiotta D,et al.Portal hypertensive gastropathy in cirrhotics without varices:a case-control study[J].Eur J Gastroenterol Hepatol,2015,27(1):91-96.
  • 7Baintner K. Suppression of ConA-indunced inflammatory ascites by li- popolysaccharide (LPS) in mice [ J ]. Acta Microbiol Immunol Hung, ~ 2012,59(3) : 387 -392.
  • 8赵宁,李智伟.肝硬化合并感染及抗菌药物治疗的研究现状[J].实用药物与临床,2008,11(5):266-269. 被引量:15
  • 9闫涛,王慧芬,李克,岳小静,王慧,张慧英,王海清,黄顺.肝衰竭合并自发性细菌性腹膜炎诊断标准比较[J].传染病信息,2009,22(5):291-293. 被引量:5
  • 10钟转华,陈渝萍.内毒素在肝硬化病情演变中的重要性及干预价值[J].河北医学,2010,16(1):25-27. 被引量:16

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部